Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Frontiers in Cellular and Infection Microbiology, 12, Frontiers Media S.A., https://doi.org/10.26083/tuprints-00022480
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek
- (wann)
-
2022
- Urheber
- DOI
-
10.26083/tuprints-00022480
- URN
-
urn:nbn:de:tuda-tuprints-224804
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Berthold, Emilia
- Ma-Lauer, Yue
- Chakraborty, Ashesh
- Brunn, Brigitte von
- Hilgendorff, Anne
- Hatz, Rudolf
- Behr, Jürgen
- Hausch, Felix
- Staab-Weijnitz, Claudia
- Brunn, Albrecht von
- Universitäts- und Landesbibliothek
Entstanden
- 2022
Ähnliche Objekte (12)
Non‐Immunosuppressive Cyclophilin Inhibitors
Coronavirus replication and reverse genetics
Amiloride and its analogs : unique cation transport inhibitors
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages
Equine coronavirus infection and replication in equine intestinal enteroids
FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
Multi-level inhibition of coronavirus replication by chemical ER stress
Inhibitors compounds of the flavivirus replication process
Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
COVIDOA: a novel evolutionary optimization algorithm based on coronavirus disease replication lifecycle
Non‐Immunosuppressive Cyclophilin Inhibitors
Coronavirus replication and reverse genetics
Amiloride and its analogs : unique cation transport inhibitors
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages
Equine coronavirus infection and replication in equine intestinal enteroids
FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
Multi-level inhibition of coronavirus replication by chemical ER stress
Inhibitors compounds of the flavivirus replication process
Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
COVIDOA: a novel evolutionary optimization algorithm based on coronavirus disease replication lifecycle
Non‐Immunosuppressive Cyclophilin Inhibitors
Coronavirus replication and reverse genetics
Amiloride and its analogs : unique cation transport inhibitors
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Resveratrol and its analogs suppress HIV replication, oxidative stress, and inflammation in macrophages
Equine coronavirus infection and replication in equine intestinal enteroids
FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
Multi-level inhibition of coronavirus replication by chemical ER stress
Inhibitors compounds of the flavivirus replication process
Tylophorine Analogs Allosterically Regulates Heat Shock Cognate Protein 70 And Inhibits Hepatitis C Virus Replication
Transcription–replication conflicts underlie sensitivity to PARP inhibitors